4.5 Article

Efficacy and effectiveness of influenza vaccination

Journal

VACCINE
Volume 26, Issue -, Pages D17-D22

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2008.07.048

Keywords

Influenza; Vaccination; Vaccine efficacy; Vaccine effectiveness

Funding

  1. Medimmune
  2. Novartis
  3. GSK
  4. CSL
  5. sanofi Pasteur

Ask authors/readers for more resources

Influenza is a major cause of morbidity and mortality. Vaccination remains the most important means of preventing and controlling influenza. A review of the published literature shows that vaccination of children, healthy younger adults, the elderly, and both children and adults with high-risk medical conditions provides substantial benefits, although the types of benefits vary by age. Vaccination also generally provides benefit even during poor match seasons. Strategies to reduce transmission within households and communities through the vaccination of school children and to reduce transmission within health care settings through the vaccination of healthcare workers are also promising. Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available